Biosimilars Access and Affordability Act Legislation by Sen. Blackburn Analyzed
Bill Intros-Senate
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-10-13
Bailey Malota
WASHINGTON, Oct. 13 -- The Biosimilars Access and Affordability Act, originally introduced by Sen. Marsha Blackburn, R-Tennessee, on September 28, 2026, has been analyzed by the Congressional Research Service. This legislation aims to amend Title XI of the Social Security Act to modify the eligibility timeline for price negotiations on biosimilar biological products under the Medicare program.
The proposed changes in the legislation are motivated by the rising costs of healthcare, p . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Oct. 13 -- The Biosimilars Access and Affordability Act, originally introduced by Sen. Marsha Blackburn, R-Tennessee, on September 28, 2026, has been analyzed by the Congressional Research Service. This legislation aims to amend Title XI of the Social Security Act to modify the eligibility timeline for price negotiations on biosimilar biological products under the Medicare program.
The proposed changes in the legislation are motivated by the rising costs of healthcare, p . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
